Skip to main content
. 2016 Oct 18;7:13132. doi: 10.1038/ncomms13132

Figure 5. Improvement of AP conduction by E-Fibs in a model of cardiac interstitial fibrosis.

Figure 5

(a) Schematic depicting use of E-Fibs to improve impaired conduction in an in vitro model of cardiac interstitial fibrosis. (b) Immunostaining corresponding to dashed-line square area in a showing vimentin+ E-HDFs in between sarcomeric α-actinin (SAA)+ neonatal rat cardiomyocytes (CMs). (ce) Average CV (c), APD80 (d) and impulse wavelength (WL=CVxAPD80, e) values during longitudinal or transverse conduction in CM-only cultures (fibrosis control), CM+wt-HDF co-cultures, CM+NavSheP D60A/Kir2.1-expressing HDF co-cultures, CM+Cx43-expressing HDF co-cultures, CM+E-HDF co-cultures and confluent anisotropic CM cultures (healthy control) (n=5–8). *P<0.001 versus transverse CVs in fibrosis control group. Error bars indicate s.e.m; statistical significance was determined by one-way analysis of variance, followed by Tukey's post-hoc test to calculate P-values.